DRAEGERWERK AG - PREF (DRW3.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:DRW3 - DE0005550636
68.4 EUR
+0.15 (+0.22%)
DRW3 gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 62 industry peers in the Health Care Equipment & Supplies industry. DRW3 has only an average score on both its financial health and profitability. DRW3 is valued quite cheap, while showing a decent growth score. This is a good combination! Finally DRW3 also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
DRW3 had positive earnings in the past year.
DRW3 had a positive operating cash flow in the past year.
Of the past 5 years DRW3 4 years were profitable.
Of the past 5 years DRW3 4 years had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 3.99%, DRW3 perfoms like the industry average, outperforming 56.92% of the companies in the same industry.
With a Return On Equity value of 8.02%, DRW3 perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
The Return On Invested Capital of DRW3 (7.67%) is better than 63.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.99% | ||
| ROE | 8.02% | ||
| ROIC | 7.67% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Profit Margin value of 3.54%, DRW3 perfoms like the industry average, outperforming 43.08% of the companies in the same industry.
In the last couple of years the Profit Margin of DRW3 has grown nicely.
DRW3 has a worse Operating Margin (6.02%) than 63.08% of its industry peers.
In the last couple of years the Operating Margin of DRW3 has grown nicely.
DRW3 has a Gross Margin of 45.35%. This is in the lower half of the industry: DRW3 underperforms 69.23% of its industry peers.
DRW3's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.02% | ||
| PM (TTM) | 3.54% | ||
| GM | 45.35% |
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DRW3 is creating some value.
DRW3 has less shares outstanding than it did 1 year ago.
DRW3 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DRW3 has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.72 indicates that DRW3 is not a great score, but indicates only limited risk for bankruptcy at the moment.
DRW3 has a Altman-Z score (2.72) which is comparable to the rest of the industry.
DRW3 has a debt to FCF ratio of 2.16. This is a good value and a sign of high solvency as DRW3 would need 2.16 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.16, DRW3 is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
A Debt/Equity ratio of 0.10 indicates that DRW3 is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.10, DRW3 is doing good in the industry, outperforming 75.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.16 | ||
| Altman-Z | 2.72 |
ROIC/WACC1.17
WACC6.55%
2.3 Liquidity
A Current Ratio of 1.76 indicates that DRW3 should not have too much problems paying its short term obligations.
The Current ratio of DRW3 (1.76) is comparable to the rest of the industry.
DRW3 has a Quick Ratio of 1.03. This is a normal value and indicates that DRW3 is financially healthy and should not expect problems in meeting its short term obligations.
DRW3 has a Quick ratio of 1.03. This is comparable to the rest of the industry: DRW3 outperforms 43.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.68% over the past year.
Measured over the past years, DRW3 shows a very strong growth in Earnings Per Share. The EPS has been growing by 36.42% on average per year.
The Revenue has been growing slightly by 2.14% in the past year.
The Revenue has been growing slightly by 3.92% on average over the past years.
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
3.2 Future
The Earnings Per Share is expected to grow by 7.93% on average over the next years.
DRW3 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.15% yearly.
EPS Next Y5.38%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
EPS Next 5Y7.93%
Revenue Next Year2.84%
Revenue Next 2Y3.51%
Revenue Next 3Y3.67%
Revenue Next 5Y3.15%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 10.60, the valuation of DRW3 can be described as reasonable.
DRW3's Price/Earnings ratio is rather cheap when compared to the industry. DRW3 is cheaper than 96.92% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.92, DRW3 is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 9.32, the valuation of DRW3 can be described as reasonable.
Based on the Price/Forward Earnings ratio, DRW3 is valued cheaply inside the industry as 90.77% of the companies are valued more expensively.
DRW3's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.6 | ||
| Fwd PE | 9.32 |
4.2 Price Multiples
95.38% of the companies in the same industry are more expensive than DRW3, based on the Enterprise Value to EBITDA ratio.
DRW3's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DRW3 is cheaper than 93.85% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.38 | ||
| EV/EBITDA | 3.73 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DRW3 does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)1.97
PEG (5Y)0.29
EPS Next 2Y11.08%
EPS Next 3Y11.69%
5. Dividend
5.1 Amount
DRW3 has a Yearly Dividend Yield of 3.46%.
Compared to an average industry Dividend Yield of 1.11, DRW3 pays a better dividend. On top of this DRW3 pays more dividend than 95.38% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, DRW3 pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.46% |
5.2 History
The dividend of DRW3 is nicely growing with an annual growth rate of 51.02%!
Dividend Growth(5Y)51.02%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DRW3 pays out 31.13% of its income as dividend. This is a sustainable payout ratio.
DRW3's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP31.13%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
FRA:DRW3 (12/23/2025, 5:29:56 PM)
68.4
+0.15 (+0.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.23%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.28B
Revenue(TTM)3.42B
Net Income(TTM)120.88M
Analysts81.33
Price Target96.91 (41.68%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.46% |
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP31.13%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.5%
PT rev (3m)8.83%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.26%
EPS NY rev (3m)2.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.6 | ||
| Fwd PE | 9.32 | ||
| P/S | 0.38 | ||
| P/FCF | 9.38 | ||
| P/OCF | 6.32 | ||
| P/B | 0.85 | ||
| P/tB | 1.1 | ||
| EV/EBITDA | 3.73 |
EPS(TTM)6.45
EY9.43%
EPS(NY)7.34
Fwd EY10.73%
FCF(TTM)7.29
FCFY10.67%
OCF(TTM)10.82
OCFY15.82%
SpS182.27
BVpS80.37
TBVpS62.21
PEG (NY)1.97
PEG (5Y)0.29
Graham Number108
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.99% | ||
| ROE | 8.02% | ||
| ROCE | 10.2% | ||
| ROIC | 7.67% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 10.67% | ||
| OM | 6.02% | ||
| PM (TTM) | 3.54% | ||
| GM | 45.35% | ||
| FCFM | 4% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score7
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.16 | ||
| Debt/EBITDA | 0.44 | ||
| Cap/Depr | 44.92% | ||
| Cap/Sales | 1.93% | ||
| Interest Coverage | 11.48 | ||
| Cash Conversion | 57.51% | ||
| Profit Quality | 113.22% | ||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.72 |
F-Score7
WACC6.55%
ROIC/WACC1.17
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
EPS Next Y5.38%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
EPS Next 5Y7.93%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
Revenue Next Year2.84%
Revenue Next 2Y3.51%
Revenue Next 3Y3.67%
Revenue Next 5Y3.15%
EBIT growth 1Y12.74%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year83.49%
EBIT Next 3Y27.99%
EBIT Next 5Y13.46%
FCF growth 1Y20.52%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y11.8%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%
DRAEGERWERK AG - PREF / DRW3.DE FAQ
Can you provide the ChartMill fundamental rating for DRAEGERWERK AG - PREF?
ChartMill assigns a fundamental rating of 5 / 10 to DRW3.DE.
What is the valuation status of DRAEGERWERK AG - PREF (DRW3.DE) stock?
ChartMill assigns a valuation rating of 7 / 10 to DRAEGERWERK AG - PREF (DRW3.DE). This can be considered as Undervalued.
How profitable is DRAEGERWERK AG - PREF (DRW3.DE) stock?
DRAEGERWERK AG - PREF (DRW3.DE) has a profitability rating of 4 / 10.
What are the PE and PB ratios of DRAEGERWERK AG - PREF (DRW3.DE) stock?
The Price/Earnings (PE) ratio for DRAEGERWERK AG - PREF (DRW3.DE) is 10.6 and the Price/Book (PB) ratio is 0.85.
What is the financial health of DRAEGERWERK AG - PREF (DRW3.DE) stock?
The financial health rating of DRAEGERWERK AG - PREF (DRW3.DE) is 5 / 10.